HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CXC 195

an anti-inflammatory agent that decreases microglial production of both nitric oxide and TNF-alpha; structure in first source
Also Known As:
CXC-195; CXC195
Networked: 8 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Chen, Lin: 4 articles (04/2017 - 01/2013)
2. Liu, Huiqing: 4 articles (04/2017 - 01/2013)
3. Liu, Xinyong: 4 articles (04/2017 - 01/2013)
4. Wei, Xinbing: 4 articles (04/2017 - 01/2013)
5. Cheng, Li: 2 articles (04/2017 - 03/2015)
6. Zhang, Xiumei: 2 articles (03/2015 - 01/2013)
7. Li, Senpeng: 2 articles (01/2014 - 01/2013)
8. Liu, Xiaoqian: 2 articles (01/2014 - 01/2013)
9. Ren, Zhiping: 1 article (04/2017)
10. Wang, Shuaishuai: 1 article (04/2017)

Related Diseases

1. Brain Ischemia (Cerebral Ischemia)
2. Reperfusion Injury
3. Neoplasms (Cancer)
4. Hepatocellular Carcinoma (Hepatoma)
5. Ischemia

Related Drugs and Biologics

1. tetramethylpyrazine
2. Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
3. Antioxidants
4. NADPH Oxidases (NAD(P)H oxidase)
5. Neuroprotective Agents
6. Lipopolysaccharides
7. Aligeron (AS 2)
8. CXC137